{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:29:04Z","timestamp":1792985344215,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.critrevonc.2024.104559","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:11:46Z","timestamp":1731705106000},"page":"104559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment"],"prefix":"10.1016","volume":"205","author":[{"given":"Pengfei","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2024.104559_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119673","article-title":"Current trends in polymer microneedle for transdermal drug delivery","volume":"587","author":"Ahmed Saeed Al-Japairai","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"8971","key":"10.1016\/j.critrevonc.2024.104559_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(95)92255-5","article-title":"Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol","volume":"346","author":"Bagot","year":"1995","journal-title":"Lancet (Lond., Engl. )"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104559_bib3","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","article-title":"The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104559_bib4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104559_bib5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamadermatol.2023.3849","article-title":"Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis","volume":"159","author":"Boesjes","year":"2023","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2015.02.014","article-title":"Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities","volume":"158","author":"Cedeno-Laurent","year":"2015","journal-title":"Clin. Immunol. (Orlando, Fla)"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104559_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160807","article-title":"Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma","volume":"133","author":"Chen","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00128071-200304020-00004","article-title":"Ceramides and skin function","volume":"4","author":"Coderch","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104559_bib10","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.jid.2021.04.023","article-title":"Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma","volume":"141","author":"Cortes","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.critrevonc.2024.104559_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1255859","article-title":"Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model","volume":"15","author":"Dey","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2024.104559_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215972","article-title":"Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma","volume":"551","author":"Du","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2024.104559_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03705.x","article-title":"Cutaneous T cell lymphoma: the helping hand of dendritic cells","volume":"941","author":"Edelson","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8923","key":"10.1016\/j.critrevonc.2024.104559_bib15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(94)92122-9","article-title":"Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin","volume":"344","author":"French","year":"1994","journal-title":"Lancet (Lond., Engl. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib16","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1038\/s41467-024-48226-z","article-title":"Three stepwise pH progressions in stratum corneum for homeostatic maintenance of the skin","volume":"15","author":"Fukuda","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104559_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00403-007-0749-6","article-title":"Expression of human beta-defensins in patients with mycosis fungoides","volume":"299","author":"Gambichler","year":"2007","journal-title":"Arch. Dermatol. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104559_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2016.03.008","article-title":"Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies","volume":"15","author":"Gilhar","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.2022016690","article-title":"Malignant T cells induce skin barrier defects through cytokine-mediated JAK\/STAT signaling in cutaneous T-cell lymphoma","volume":"141","author":"Gluud","year":"2023","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.critrevonc.2024.104559_bib20","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","article-title":"TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma","volume":"19","author":"Guenova","year":"2013","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"6596","key":"10.1016\/j.critrevonc.2024.104559_bib21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1126\/science.abo0693","article-title":"Microbiota and maintenance of skin barrier function","volume":"376","author":"Harris-Tryon","year":"2022","journal-title":"Sci. (N. Y., NY)"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib22","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.12788\/cutis.0074","article-title":"Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma","volume":"106","author":"Hollins","year":"2020","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.26760","article-title":"Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Hristov","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100329","article-title":"Dysregulated ceramide metabolism in mouse progressive dermatitis resulting from constitutive activation of Jak1","volume":"64","author":"Iino","year":"2023","journal-title":"J. Lipid Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib26","first-page":"8","article-title":"Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene","volume":"26","author":"Incel Uysal","year":"2018","journal-title":"Acta Dermatovenerol. Croat.: ADC"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.08.033","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104559_bib28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.0022-202X.2005.23935.x","article-title":"High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis","volume":"125","author":"de Jongh","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104559_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051324","article-title":"The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas","volume":"14","author":"Jost","year":"2022","journal-title":"Cancers"},{"issue":"Pt 17","key":"10.1016\/j.critrevonc.2024.104559_bib30","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1242\/jcs.114.17.3069","article-title":"Assembly of the epidermal cornified cell envelope","volume":"114","author":"Kalinin","year":"2001","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104559_bib31","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/jid.2008.29","article-title":"Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum","volume":"128","author":"Kezic","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.critrevonc.2024.104559_bib32","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2024.104559_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2016.04.001","article-title":"Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides","volume":"63","author":"Kihara","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin. Immunol. (Orlando, Fla)"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","article-title":"Skin barrier dysfunction and filaggrin","volume":"44","author":"Kim","year":"2021","journal-title":"Arch. Pharmacal Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104559_bib36","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle (Georget., Tex. )"},{"issue":"6490","key":"10.1016\/j.critrevonc.2024.104559_bib37","article-title":"Antimicrobial peptides: Application informed by evolution","volume":"368","author":"Lazzaro","year":"2020","journal-title":"Sci. (N. Y., NY)"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104559_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","article-title":"Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches","volume":"134","author":"Leung","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ijd.13832","article-title":"The \"Duvic regimen\" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Lewis","year":"2018","journal-title":"Int J. Dermatol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104559_bib40","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/jdv.15075","article-title":"Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma","volume":"32","author":"Lewis","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jms.4048","article-title":"Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice","volume":"53","author":"Le","year":"2018","journal-title":"J. Mass Spectrom.: JMS"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41522-024-00542-4","article-title":"The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival","volume":"10","author":"Licht","year":"2024","journal-title":"NPJ Biofilms Micro"},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104559_bib43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.2018888107","article-title":"Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma","volume":"134","author":"Lindahl","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1523-1747.2003.12359.x","article-title":"Barrier function of the skin: \"la raison d\u2032\u00eatre\" of the epidermis","volume":"121","author":"Madison","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2340\/00015555-1958","article-title":"Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease","volume":"95","author":"Malek","year":"2015","journal-title":"Acta Derm. -Venereol."},{"key":"10.1016\/j.critrevonc.2024.104559_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101264","article-title":"The heterogeneity and complexity of skin surface lipids in human skin health and disease","volume":"93","author":"Mijaljica","year":"2024","journal-title":"Prog. Lipid Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104559_bib47","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/jid.2010.128","article-title":"Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma","volume":"130","author":"Miyagaki","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib48","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1468-3083.2012.04495.x","article-title":"Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis","volume":"27","author":"Miyagaki","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"26","key":"10.1016\/j.critrevonc.2024.104559_bib49","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2340\/00015555-1345","article-title":"Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma","volume":"92","author":"Ohmatsu","year":"2012","journal-title":"Acta Derm. -Venereol."},{"issue":"19","key":"10.1016\/j.critrevonc.2024.104559_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910841","article-title":"Skin Barrier Dysregulation in Psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104559_bib52","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jid.2023.01.039","article-title":"Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma","volume":"143","author":"Pallesen","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104559_bib53","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/ijd.16388","article-title":"Cutaneous T-cell lymphoma following dupilumab use: a systematic review","volume":"62","author":"Park","year":"2023","journal-title":"Int. J. Dermatol."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104559_bib54","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00018-005-5540-2","article-title":"Human beta-defensins","volume":"63","author":"Pazgier","year":"2006","journal-title":"Cell. Mol. life Sci.: CMLS"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104559_bib55","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2326-6066.CIR-17-0270","article-title":"Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile","volume":"6","author":"Querfeld","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"19","key":"10.1016\/j.critrevonc.2024.104559_bib56","doi-asserted-by":"crossref","first-page":"13317","DOI":"10.1021\/jacs.4c01720","article-title":"RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor","volume":"146","author":"Rafic","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/biom5020545","article-title":"Oxidative stress in aging human skin","volume":"5","author":"Rinnerthaler","year":"2015","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104559_bib58","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jaci.2022.02.015","article-title":"T cells in the skin: Lymphoma and inflammatory skin disease","volume":"149","author":"Roediger","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CCO.0000000000000243","article-title":"Tumor microenvironment in mycosis fungoides and S\u00e9zary syndrome","volume":"28","author":"Rubio Gonzalez","year":"2016","journal-title":"Curr. Opin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104559_bib60","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2009.06.082","article-title":"High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma","volume":"62","author":"Schlapbach","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8864","key":"10.1016\/j.critrevonc.2024.104559_bib61","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0140-6736(93)91373-T","article-title":"Calcipotriol and regression in T-cell lymphoma of skin","volume":"342","author":"Scott-Mackie","year":"1993","journal-title":"Lancet (Lond., Engl. )"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2018.02.011","article-title":"Pruritus in Cutaneous T-Cell Lymphoma and Its Management","volume":"36","author":"Serrano","year":"2018","journal-title":"Dermatol. Clin."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jdermsci.2007.12.004","article-title":"Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides","volume":"50","author":"Shimauchi","year":"2008","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jid.2019.06.142","article-title":"Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides","volume":"140","author":"Smits","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.critrevonc.2024.104559_bib65","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fcell.2020.00851","article-title":"Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma","volume":"8","author":"Stolearenco","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"16","key":"10.1016\/j.critrevonc.2024.104559_bib66","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-14-0077","article-title":"Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma","volume":"20","author":"Suga","year":"2014","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104559_bib67","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.4049\/jimmunol.174.8.4870","article-title":"Differential regulation of beta-defensin expression in human skin by microbial stimuli","volume":"174","author":"S\u00f8rensen","year":"2005","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104559_bib68","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-16-0992","article-title":"Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma","volume":"76","author":"Takahashi","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2008.08612.x","article-title":"Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and S\u00e9zary syndrome","volume":"159","author":"Talpur","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104559_bib70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clml.2014.06.023","article-title":"Vitamin D deficiency in mycosis fungoides and S\u00e9zary syndrome patients is similar to other cancer patients","volume":"14","author":"Talpur","year":"2014","journal-title":"Clin. Lymphoma, Myeloma Leuk."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104559_bib71","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.2019004256","article-title":"Genetic and epigenetic insights into cutaneous T-cell lymphoma","volume":"139","author":"Tensen","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib73","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/jid.2014.284","article-title":"Malignant T cells secrete galectins and induce epidermal hyperproliferation and disorganized stratification in a skin model of cutaneous T-cell lymphoma","volume":"135","author":"Thode","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104559_bib74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1995.tb02485.x","article-title":"Cutaneous colonization with staphylococci influences the disease activity of S\u00e9zary syndrome: a potential role for bacterial superantigens","volume":"133","author":"Tokura","year":"1995","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/nu12030862","article-title":"Expression Profiles of Genes Encoding Cornified Envelope Proteins in Atopic Dermatitis and Cutaneous T-Cell Lymphomas","volume":"12","author":"Trzeciak","year":"2020","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104559_bib76","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2023021671","article-title":"Staphylococcus aureus induces drug resistance in cancer T cells in S\u00e9zary syndrome","volume":"143","author":"Vadivel","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2024.104559_bib77","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: A smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104559_bib78","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/med.21542","article-title":"Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era","volume":"39","author":"Wang","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020270","article-title":"C6 Ceramide (d18:1\/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma","volume":"13","author":"Wilhelm","year":"2021","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.critrevonc.2024.104559_bib80","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104559_bib81","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104559_bib82","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jid.2021.01.038","article-title":"Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5-Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma","volume":"141","author":"Willerslev-Olsen","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104559_bib83","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","volume":"127","author":"Willerslev-Olsen","year":"2016","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.critrevonc.2024.104559_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/nu15173842","article-title":"Infections and Autoimmunity-The Immune System and Vitamin D: A Systematic Review","volume":"15","author":"Wimalawansa","year":"2023","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104559_bib85","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2006-04-017863","article-title":"Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins","volume":"109","author":"Woetmann","year":"2007","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104559_bib86","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1158\/1078-0432.CCR-14-0707","article-title":"Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function","volume":"20","author":"Wolk","year":"2014","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104559_bib87","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/10428194.2018.1516037","article-title":"IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model","volume":"60","author":"Wu","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104559_bib88","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/jid.2014.206","article-title":"Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo","volume":"134","author":"Wu","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104559_bib89","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1172\/JCI82887","article-title":"Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis","volume":"126","author":"Yasuda","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.critrevonc.2024.104559_bib90","unstructured":"Yousef H., Alhajj M., Fakoya A.O., Sharma S. Anatomy, Skin (Integument), Epidermis. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Mandy Alhajj declares no relevant financial relationships with ineligible companies. Disclosure: Adegbenro Fakoya declares no relevant financial relationships with ineligible companies. Disclosure: Sandeep Sharma declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"issue":"31","key":"10.1016\/j.critrevonc.2024.104559_bib91","doi-asserted-by":"crossref","first-page":"18991","DOI":"10.1074\/jbc.R115.645085","article-title":"Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface","volume":"290","author":"Zackular","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104559_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060503","article-title":"Vitamin D in Cutaneous T-Cell Lymphoma","volume":"13","author":"\u00d8dum","year":"2024","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104559_bib93","article-title":"The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)-A Narrative Review","volume":"11","author":"\u0141yko","year":"2022","journal-title":"Pathog. (Basel, Switz. )"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104559_bib94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbamem.2015.11.019","article-title":"Ceramides with a pentadecasphingosine chain and short acyls have strong permeabilization effects on skin and model lipid membranes","volume":"1858","author":"\u0160kolov\u00e1","year":"2016","journal-title":"Biochim. Et. Biophys. Acta"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824003020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824003020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T03:23:53Z","timestamp":1734405833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824003020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":94,"alternative-id":["S1040842824003020"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104559","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104559"}}